PeterBio
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
75 Kneeland St Fl 14, Boston, Massachuse...Website
www.peterbio.comRevenue
<$5 MillionIndustry
About PeterBio
PeterBio Org Chart
Is PeterBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at PeterBio
Earning: See what the market has to say on PeterBio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
PeterBio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when PeterBio launches new products
Website visits: Recent activity has been detected on your website
Check out if PeterBio is spiking on competitors!
Click to see if PeterBio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once PeterBio has new funding data
Check if PeterBio has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at PeterBio
Find 2 more new buyers
Company Profile Activity
Activity Insights
PeterBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PeterBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PeterBio.
PeterBio Tech Stack
A closer look at the technologies used by PeterBio
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PeterBio
PeterBio is a Boston-based biotech company specializing in innovative gene and cell therapies, particularly through their breakthrough gene-editing technology known as RITDM. The company focuses on developing safe and effective treatments for genetic diseases, including metabolic disorders, sickle cell disease, and oncology. Their priority is to cr... Read More